Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country

Jenkins Helen E., Plesca Valeriu, Ciobanu Anisoara, Crudu Valeriu, Galusca Irina, Soltan Viorel, Serbulenco Aliona, Zignol Matteo, Dadu Andrei, Dara Masoud, Cohen Ted

Source: Eur Respir J 2013; 42: 1291-1301

Journal Issue: November

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jenkins Helen E., Plesca Valeriu, Ciobanu Anisoara, Crudu Valeriu, Galusca Irina, Soltan Viorel, Serbulenco Aliona, Zignol Matteo, Dadu Andrei, Dara Masoud, Cohen Ted. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J 2013; 42: 1291-1301

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020 Year: 2021
Trends of multidrug-resistant tuberculosis clustering in Portugal Source: ERJ Open Res, 5 (1) 00151-2018; 10.1183/23120541.00151-2018 Year: 2019
Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration Source: Eur Respir J 2016; 47: 686-688 Year: 2016
HIV and multidrug-resistant tuberculosis: overlapping epidemics Source: Eur Respir J 2014; 44: 251-254 Year: 2014
Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012
TB drug resistance in high-incidence countries Source: Eur Respir Mon 2012; 58: 95-110 Year: 2012
Detection of latent tuberculosis in a low-prevalence country Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city Source: Eur Respir J 2013; 41: 901-908 Year: 2013
Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia Source: Eur Respir J, 52 (6) 1801218; 10.1183/13993003.01218-2018 Year: 2018
Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Analysis of multidrug-resistant tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Multidrug-resistant tuberculosis in children: evidence from global surveillance Source: Eur Respir J 2013; 42: 701-707 Year: 2013
Changes in treatment for multidrug-resistant tuberculosis according to national income Source: Eur Respir J, 56 (5) 2001394; 10.1183/13993003.01394-2020 Year: 2020
Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008
Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India? Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012
The global risk of dying from multidrug-resistant tuberculosis (MDR-TB) Source: International Congress 2014 – Tuberculosis epidemiology: novel features Year: 2014